Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Frequency, Determinants, and Costs of Recommendations for Additional Imaging in Clinical F-18-FDG PET/CT Reports
Published in: Journal of Nuclear Medicine
Access to document
10.2967/jnumed.118.223362
document
Our purpose was to determine the frequency, determinants, and costs of recommendations for additional imaging (RAIs) in clinical F-18-FDG PET/CT reports. Methods: This retrospective study included a random sample of 2,643 F-18-FDG PET/CT scans that were performed for various clinical reasons at a tertiary-care academic medical center without financial incentives for self-referral, within a 1.5-y period. Results: Ninety-eight (3.7%) of 2,643 F-18-FDG PET/CT reports contained an RAI. None of the investigated variables (patient age, hospital status [inpatient or outpatient], indication for F-18-FDG PET/CT scanning [oncologic, infection/inflammation, or miscellaneous],...
Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: : related to fibrosis?
Published in: EJNMMI Research
Access to document
10.1186/s13550-019-0549-y
document
RATIONALE: The use of 16α-[18F]fluoro-17β-estradiol (FES) positron emission tomography (PET) in clinical dilemmas and for therapy decision-making in lesions expressing estrogen receptors is growing. However, on a considerable number of FES PET scans, previously performed in a research and clinical setting in our institution, FES uptake was noticed in the lungs without an oncologic substrate. We hypothesized that this uptake was related to pulmonary fibrosis as a result of radiation therapy. This descriptive study therefore aimed to investigate whether radiation therapy in the thoracic area is possibly related...
C M Venema, E F J de Vries, S J van der Veen, M D Dorrius, M van Kruchten, C P Schröder, G A P Hospers, A W J M Glaudemans
Relationship between semiquantitative 18F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma
Published in: Scientific Reports
Access to document
10.1038/s41598-019-47453-5
document
Semiquantitative 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) parameters have been proposed as prognostic markers in classical Hodgkin lymphoma (cHL). In non-Hodgkin lymphoma necrosis as assessed by 18F-FDG PET or computed tomography (CT) (necrosisvisual) correlates with an adverse prognosis. We investigated whether semiquantitative 18F-FDG PET metrics correlate with necrosisvisual, determined the incidence of necrosisvisual and explored the prognostic impact of these factors in cHL. From 87 cHL cases treated with ABVD, (escalated) BEACOPP or CHOP chemotherapy between 2010 and 2017, 71 had both a NEDPAS/EARL accredited 18F-FDG PET and...
X U Kahle, F M Montes de Jesus, T C Kwee, T van Meerten, A Diepstra, S Rosati, A W J M Glaudemans, W Noordzij, W J Plattel, M Nijland
Publisher Correction: In vitro imaging of bacteria using 18F-fluorodeoxyglucose micro positron emission tomography
Published in: Scientific Reports
Access to document
10.1038/s41598-019-46786-5
document
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Diagnosing fracture-related infections: can we optimize our nuclear imaging techniques?
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-019-04378-5
document
Andor W. J. M. Glaudemans, Paul Bosch, Riemer H. J. A. Slart, Frank F. A. IJpma, Geertje A. M. Govaert